A platelet recipient whose HLA phenotype includes A3, B7; A11, B42 is transfused from a A1, B7; A3, B13 donor. Given the following CREG (Cross-Reactive Groups) , what would you expect the outcome of this transfusion to be? A1-CREG: A1,36,3,9(23,24) ,10(25,26,34,66) ,11, 19(29,30,31,32,33) 28 B7-CREG: B7,42,22(54,55,56) ,27,40(60,61) 13,41,47,48
A) The donor would experience platelet refractoriness because A3 and A11 and B13 and B42 are not cross-reactive.
B) The donor would benefit from this transfusion because A3 and A11 and B13 and B42 are cross-reactive.
C) The recipient would experience platelet refractoriness because A3 and A11 and B13 and B42 are not cross-reactive.
D) The recipient would benefit from this transfusion because A3 and A11 and B13 and B42 are cross-reactive.
Correct Answer:
Verified
Q28: How are monoclonal HLA antibodies (MoAbs) produced?
A)
Q29: The genetic region that contains surface antigens
Q30: What is the main purpose of crossmatching
Q31: When the entire set of A, B,
Q32: Recipient lymphocytotoxic HLA-antibody to donor antigens is
Q34: Which MHC region encodes for complement proteins?
A)
Q35: Which of the following is acceptable for
Q36: MHC class II molecules are expressed on
Q37: Kidney transplants are used to treat which
Q38: Why are T cells unacceptable for cytotoxicity
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents